Literature DB >> 20887552

The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.

Y Hamajima1, M Komori, D A Preciado, D I Choo, K Moribe, S Murakami, F G Ondrey, J Lin.   

Abstract

OBJECTIVES: A hallmark of cholesteatoma is hyperproliferation of keratinocytes with abundant production of keratins in the middle ear under chronic inflammatory conditions. However, little is known about the driving force of cellular proliferation and keratin production of cholesteatomal matrix. The purpose of this study was to investigate the cellular proliferation and keratin production of keratinocytes under the influence of Id1, a candidate transcription factor to cell proliferation.
MATERIALS AND METHODS: Keratinocytes were transfected with Id1 and the responses of keratinocytes to Id1 were studied by using cellular and molecular biologic methods.
RESULTS: Id1 positively contributed to the cell cycle progression and negatively to the p16(Ink4a) downregulation via the nuclear factor-kappa B (NF-κB)/cyclin D1 pathway. Id1 significantly increased the promoter activity of NF-κB which, in turn, up-regulated the expression of cyclin D1 and keratin 10 in keratinocytes. Specific NF-κB inhibitors (pyrrolidine dithiocarbamate, PDTC), or dominant-negative inhibitor (I kappa B alpha mutant, IκBαM) abrogated the Id1-induced cell proliferation and keratin 10 production whereas p65, a subunit of the NF-κB heterodimer and an enhancer of the NF-κB activity, strengthened the Id1-induced cell proliferation and keratin 10 production.
CONCLUSIONS: Id1 contributed to hyperproliferation of keratinocytes via enhancement of cell cycle progression, removal of cell cycle inhibition, and simultaneously increased keratin production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887552      PMCID: PMC2950310          DOI: 10.1111/j.1365-2184.2010.00695.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  Temperature-sensitive SV40-immortalized rat middle ear epithelial cells.

Authors:  Katsuhiro Toyama; Youngki Kim; Michael M Paparella; Jizhen Lin
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-12       Impact factor: 1.547

2.  Characterization of a temperature-sensitive mouse middle ear epithelial cell line.

Authors:  Katsuyuki Tsuchiya; Youngki Kim; Frank G Ondrey; Jizhen Lin
Journal:  Acta Otolaryngol       Date:  2005-08       Impact factor: 1.494

3.  Identification of Id1 in acquired middle ear cholesteatoma.

Authors:  Quan-An Zhang; Yuki Hamajima; Qing Zhang; Jizhen Lin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-03

Review 4.  Id helix-loop-helix proteins in cell growth and differentiation.

Authors:  J D Norton; R W Deed; G Craggs; F Sablitzky
Journal:  Trends Cell Biol       Date:  1998-02       Impact factor: 20.808

Review 5.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

Review 6.  p16INK4A as a human tumor suppressor.

Authors:  G I Shapiro; B J Rollins
Journal:  Biochim Biophys Acta       Date:  1996-03-18

7.  Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.

Authors:  D R Roop; T M Krieg; T Mehrel; C K Cheng; S H Yuspa
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

8.  Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.

Authors:  S Ergün; X Zheng; B Carlsöö
Journal:  Acta Otolaryngol       Date:  1994-05       Impact factor: 1.494

Review 9.  Epidermal differentiation: the bare essentials.

Authors:  E Fuchs
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

Review 10.  It's got you covered. NF-kappaB in the epidermis.

Authors:  C K Kaufman; E Fuchs
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

View more
  9 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.

Authors:  Ela Araz Server; Çiğdem Kalaycık Ertugay; Sevim Baykal Koca; Ecem Sevim Longur; Özgür Yiğit; Hasan Demirhan; Yasemin Çakır
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

3.  Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect.

Authors:  Kristaps Dambergs; Gunta Sumeraga; Māra Pilmane
Journal:  Iran J Otorhinolaryngol       Date:  2022-03

Review 4.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 5.  Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.

Authors:  Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

6.  Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice.

Authors:  Jinhuo Lai; Qian Cai; Merrill A Biel; Chuan Wang; Xiaohua Hu; Shaoyuan Wang; Jizhen Lin
Journal:  Int J Oncol       Date:  2014-02-21       Impact factor: 5.650

Review 7.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

8.  Risk of Acquired Cholesteatoma and External Auditory Canal Stenosis in Traumatic Brain Injury: A Nationwide Population-Based Cohort Study.

Authors:  Hung-Che Lin; Cheng-Ping Shih; Hsin-Chien Chen; Chun-An Cheng; Yuahn-Sieh Huang; Chen-Shien Lin; Chi-Hsian Chung; Bor-Rong Huang; Jih-Chin Lee; Wei-Chuan Shangkuan; Wu-Chien Chien; Chi-Ming Chu
Journal:  Int J Environ Res Public Health       Date:  2020-09-11       Impact factor: 3.390

9.  Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.

Authors:  Carlos Eduardo Borges Rezende; Ricardo Peres do Souto; Priscila Bogar Rapoport; Laís de Campos; Marcela Bovo Generato
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.